share_log

Nikola | EFFECT: Others

Nikola | EFFECT: Others

Nikola | EFFECT:其他
美股SEC公告 ·  08/29 06:25

Moomoo AI 已提取核心訊息

The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.
美國證券交易委員會(SEC)宣佈了TC BioPharm(Holdings)plc的F-1表格的生效。該通知顯示該表格於2024年8月28日下午4:00生效。這種表格通常由外國私有發行人用於在美國註冊其證券的銷售。該表格的生效表示TC BioPharm(Holdings)plc已滿足必要的SEC要求,可以進行證券銷售。
美國證券交易委員會(SEC)宣佈了TC BioPharm(Holdings)plc的F-1表格的生效。該通知顯示該表格於2024年8月28日下午4:00生效。這種表格通常由外國私有發行人用於在美國註冊其證券的銷售。該表格的生效表示TC BioPharm(Holdings)plc已滿足必要的SEC要求,可以進行證券銷售。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息